scholarly journals COVID-19 vaccine-induced Radiation Recall Phenomenon: report of a case

2021 ◽  
Author(s):  
Mozhdeh Sepaskhah ◽  
Fatemeh Ansari Asl ◽  
Mehrnoosh Taheri ◽  
Mojgan Akbarzadeh Jahromi
Keyword(s):  
Inflammatory Process ◽  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Radiation Recall Phenomenon (RRP) is an inflammatory process in the site of irradiation, induced by physical and medical agents. Few cases of RRP in the skin and lung have been reported after COVID-19 vaccination. Here, we report radiation recall dermatitis after both doses of inactivated SARS-CoV-2 vaccine (Sinopharm, China).

Recurrent radiation recall dermatitis 40 years after radiation therapy for breast cancer

2021 ◽  
Author(s):  
Muhammad F. Jamaluddin ◽  
Aswin G. Abraham ◽  
Geetha Menon ◽  
Thomas Nakatsui ◽  
Wilson Roa
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

A case of potential radiation recall dermatitis induced by chemotherapy, following low-dose total-skin electron beam therapy

2019 ◽  
Vol 29 (6) ◽  
pp. 671-672 ◽  
Author(s):  
Carl Lamoureux ◽  
Emilie Gerard ◽  
Nora Ouhabrache ◽  
Feyrouz Toukal ◽  
Anne Pham-Ledard ◽  
...  
Keyword(s):  
Electron Beam ◽  
Low Dose ◽  
Radiation Recall ◽  
Electron Beam Therapy ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Radiation recall dermatitis and pneumonitis induced by trastuzumab (Herceptin®)

2013 ◽  
Vol 53 (3) ◽  
pp. e159-e160 ◽  
Author(s):  
Hae Eul Lee ◽  
Nam Ji Jeong ◽  
Young Lee ◽  
Young Joon Seo ◽  
Chang Deok Kim ◽  
...  
Keyword(s):  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Radiation Recall Dermatitis Secondary to Dactinomycin

2016 ◽  
Vol 33 (5) ◽  
pp. e278-e279 ◽  
Author(s):  
Brea Prindaville ◽  
Kimberly A. Horii ◽  
Kristi M. Canty
Keyword(s):  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

scholarly journals Radiation Recall Dermatitis in Patients Treated with Sorafenib

2018 ◽  
Vol 2018 ◽  
pp. 1-3 ◽  
Author(s):  
Keyur Mehta ◽  
Andreas Kaubisch ◽  
Justin Tang ◽  
Aneesh Pirlamarla ◽  
Shalom Kalnicki
Keyword(s):  
Chemotherapeutic Agent ◽  
Review Of The Literature ◽  
Radiation Recall ◽  
Case Presentation ◽  
Palliative Radiation Therapy ◽  
Metastatic Hepatocellular Carcinoma ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis ◽  
The Right ◽  
Carcinoma Lesion

Introduction. Radiation recall dermatitis (RRD) is a phenomenon that occurs in previously irradiated areas shortly after administration of a chemotherapeutic agent. As the use of sorafenib expands, the incidence of radiation recall dermatitis induced by sorafenib will likely increase. Here, we report on a patient who developed RRD and describe his clinical characteristics along with a review of the literature. Case Presentation. Our patient was treated with palliative radiation therapy (RT) to a painful metastatic hepatocellular carcinoma lesion in the right forearm. He completed his radiation course with grade 1 dermatitis, which had resolved by the time he was started on sorafenib 400 mg twice daily 7 days afterwards. On the 21st day after RT, he presented with desquamation and erythema in the previously irradiated area of the right forearm, consistent with RRD. The sorafenib was discontinued and his symptoms subsequently resolved with conservative topical management. Conclusions. Although the pathophysiologic mechanism of sorafenib-related radiation recall dermatitis remains to be investigated, practitioners should be aware of its presence and management in order to improve clinical outcomes.

Radiation Recall Dermatitis Consecutive to Cabozantinib Use

2019 ◽  
Vol 26 (4) ◽  
pp. e559-e561 ◽  
Author(s):  
Vivek Kumar ◽  
Trishala Meghal ◽  
Elisa Wu ◽  
Yiwu Huang
Keyword(s):  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Stevens-Johnson syndrome associated with radiation recall dermatitis in a patient treated with nivolumab

2018 ◽  
Vol 28 (3) ◽  
pp. 380-381 ◽  
Author(s):  
Laurie Rouyer ◽  
Anne-Claire Bursztejn ◽  
Laurent Charbit ◽  
Jean-Luc Schmutz ◽  
Sandra Moawad
Keyword(s):  
Stevens Johnson Syndrome ◽  
Radiation Recall ◽  
Johnson Syndrome ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

scholarly journals Radiation Recall Dermatitis after Treatment with Paclitaxel and Cisplatin

2012 ◽  
Vol 24 (2) ◽  
pp. 223 ◽  
Author(s):  
Seung Woo Baek ◽  
Young Joon Seo ◽  
Jun Sang Kim ◽  
Hyo Jin Lee
Keyword(s):  
Radiation Recall ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

scholarly journals Trastuzumab induced radiation recall dermatitis: an interesting case

2018 ◽  
Vol 7 (12) ◽  
pp. 2465
Author(s):  
Anupama C. ◽  
Anuradha H. V. ◽  
Vinayak V. Maka
Keyword(s):  
Ductal Carcinoma ◽  
Growth Factor Receptor ◽  
Radical Mastectomy ◽  
Left Breast ◽  
Interesting Case ◽  
Axillary Lymph ◽  
Radiation Recall ◽  
Skin Reactions ◽  
Radiation Recall Dermatitis ◽  
Recall Dermatitis

Radiation recall dermatitis (RRD) is the appearance of skin reactions in previously irradiated skin which is triggered by the administration of certain drugs. Surgery, chemotherapy, and radiotherapy are the mainstay of treatment in breast cancer. RRD induced by trastuzumab has been rarely reported in India. This is a case report of a 56-year-old woman presented to the medical oncology outpatient department of our hospital with breast lump, and she was diagnosed to have human epidermal growth factor receptor 2 (HER-2/neu) positive invasive ductal carcinoma of left breast of stage T2N3cM0. She was treated with neoadjuvant chemotherapy, and she underwent modified radical mastectomy with axillary lymph node dissection. The treating oncologist was planned to start on adjuvant chemotherapy with injection trastuzumab for every four weeks, for 15 cycles. Patient received first dose of injection trastuzumab (450 mg) intravenously in the right (contralateral) arm and developed painful, swollen, erythematous blisters, and maculopapular rashes following the sharp linear borders of her previous radiation fields. She was reviewed by the medical oncologist and diagnosed as a rare case of RRD and treated with topical betamethasone cream. Causality assessment for RRD to trastuzumab was done using Naranjo and WHO-UMC scale and found to be in the category of probable and probable/ likely respectively.

Sign in / Sign up

Export Citation Format

Share Document